Online inquiry

IVTScrip™ mRNA-Human ABRACL, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A))   (CAT#: GTTS-WK12382MR)

This product GTTS-WK12382MR is a type of mRNA having 120 nt poly(A) tail and modified with Cap 0 & 5-Methyl-CTP & Pseudo-UTP. It ecodes the ABRACL protein. This product can be used in Oligodendrocyte progenitor cell-related researches.
Specifications
Product type mRNA
Modified bases 5-Methyl-CTP & Pseudo-UTP
5' Cap Cap 1
Species Human
RefSeq NM_021243.3
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 58527
UniProt ID Q9P1F3
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human ABRACL, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) (GTTS-WK12382MR). Click the button above to contact us or submit your feedback about this product.
See other products
CAT Product Name Product Type CDs
GTTS-WK25320MR IVTScrip™ mRNA-Human ARHGEF4, (Cap 1, Pseudo-UTP, 120 nt-poly(A)) mRNA ARHGEF4
GTTS-WK22920MR IVTScrip™ mRNA-Human ARHGEF4, (Cap 0, 5-Methyl-CTP, 120 nt-poly(A)) mRNA ARHGEF4
GTTS-WK0602MR IVTScrip™ mRNA-Human Synaptophysin, (Cap 0, 5-Methoxy-UTP, 120 nt-poly(A)) mRNA Synaptophysin
GTTS-WK19744MR IVTScrip™ mRNA-Human Annexin V, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA Annexin V
GTTS-WK25619MR IVTScrip™ mRNA-Human ARHGEF39, (Cap 1, N1-Methylpseudo-UTP, 120 nt-poly(A)) mRNA ARHGEF39
GTTS-WK19742MR IVTScrip™ mRNA-Human ANKZF1, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA ANKZF1
GTTS-WK7993MR IVTScrip™ mRNA-Human ADAM22, (Cap 0, 5-Methoxy-UTP, 120 nt-poly(A)) mRNA ADAM22
GTTS-WK22907MR IVTScrip™ mRNA-Human ARHGEF10, (Cap 0, 5-Methyl-CTP, 120 nt-poly(A)) mRNA ARHGEF10
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
webinar

EABR Nanoparticles as a Platform Technology for Hybrid mRNA Vaccine Development

November 20th, 2024, 2 PM–3 PM EST

REGISTER NOW